BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21641821)

  • 1. Adjuvant therapy with methylene blue in the treatment of postoperative vasoplegic syndrome caused by carcinoid crisis after tricuspid valve replacement.
    Raikhelkar JK; Weiss AJ; Maysick L; Scurlock C
    J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):878-9. PubMed ID: 21641821
    [No Abstract]   [Full Text] [Related]  

  • 2. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated severe tricuspid regurgitation: the importance of identifying underlying mechanism.
    Poh KK; Solis J; Hung J
    Int J Cardiol; 2008 Jul; 127(3):403-5. PubMed ID: 17628723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy with methylene blue in the treatment of right ventricular failure after pulmonary embolectomy.
    Raikhelkar JK; Milla F; Darrow B; Scurlock C
    Heart Lung Circ; 2011 Apr; 20(4):234-6. PubMed ID: 20952252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double bioprosthetic valve replacement in right-sided carcinoid heart disease.
    Voigt PG; Braun J; Teng OY; Koolbergen DR; Holman E; Bax JJ; Smit VT; Dion RA
    Ann Thorac Surg; 2005 Jun; 79(6):2147-9. PubMed ID: 15919333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricuspid valve replacement for carcinoid heart disease to allow liver transplantation.
    Jaussaud N; Gariboldi V; Thuny F; Camerlo A; Grisoli D; Collart F; Le Treut YP; Riberi A
    J Heart Valve Dis; 2009 Nov; 18(6):728-9. PubMed ID: 20099727
    [No Abstract]   [Full Text] [Related]  

  • 7. A 51-year-old patient with carcinoid heart disease and severe tricuspid regurgitation.
    Florczak E; Pęczkowska M; Konka M; Różański J; Kolasińska-Ćwikła A
    Kardiol Pol; 2017; 75(2):183. PubMed ID: 28205198
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary ovarian carcinoid heart disease curatively treated with a two-stage procedure.
    Bonaros N; Müller S; Bonatti J; Kafka R; Tzankov A; Bale R; Bartel T
    Thorac Cardiovasc Surg; 2007 Oct; 55(7):467-9. PubMed ID: 17902075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for left-sided carcinoid heart disease.
    Senaratna SC; Knight JL; Thomas A
    ANZ J Surg; 2004 Dec; 74(12):1137-9. PubMed ID: 15574168
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass].
    Lehot JJ
    Ann Fr Anesth Reanim; 2012 May; 31 Suppl 1():S18-21. PubMed ID: 22721515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI and CT revealing carcinoid heart disease.
    Mollet NR; Dymarkowski S; Bogaert J
    Eur Radiol; 2003 Dec; 13 Suppl 4():L14-8. PubMed ID: 15018160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of high-dose hydroxocobalamin for vasoplegic syndrome.
    Roderique JD; VanDyck K; Holman B; Tang D; Chui B; Spiess BD
    Ann Thorac Surg; 2014 May; 97(5):1785-6. PubMed ID: 24792267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful tricuspid valve replacement and pulmonary valvulotomy for carcinoid heart disease.
    Defraigne JO; Jerusalem O; Soyeur D; Jacquet N; Limet R
    Acta Chir Belg; 1996; 96(4):170-6. PubMed ID: 8830875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical presentation of a carcinoid syndrome].
    Sirois I; Pothier J; Couture C; Bolduc P
    Can J Cardiol; 1999 Apr; 15(4):469-71. PubMed ID: 10322257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross sectional echocardiographic feature in carcinoid heart disease. A mechanism for tricuspid regurgitation in this syndrome.
    Davies MK; Lowry PJ; Littler WA
    Br Heart J; 1984 Mar; 51(3):355-7. PubMed ID: 6696814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoid heart disease: case and literature review.
    Dumoulein M; Verslype C; van Cutsem E; Meuris B; Herijgers P; Flameng W; Herregods MC
    Acta Cardiol; 2010 Apr; 65(2):261-4. PubMed ID: 20458839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
    Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
    Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Echocardiographic detection of tricuspid insufficiency in carcinoid heart syndrome - case report].
    Polster J; Klapdor R; Langenstein BA; Hanrath P
    Z Kardiol; 1982 Oct; 71(10):689-90. PubMed ID: 7157923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative Management of Carcinoid Heart Disease for Valvular Surgery.
    Dalal A; Stone M
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):1046-9. PubMed ID: 26776749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.